Value proposition

We envision a world in which access to life-changing therapies transforms human health.

Cytiva, now with the life sciences business from Pall Corporation, is a global biotechnology leader dedicated to helping customers discover and commercialize the next generation of therapeutics. We bring dedicated technical expertise and a broad portfolio of tools, technologies, and services that enable the development, manufacture, and delivery of transformative medicines to patients.

We are part of Danaher, a global science and technology leader. Along with other Danaher businesses, we accelerate the impact of tomorrow’s science and technology innovation to improve human health.

Visit cytiva.com to learn more.

Biotechnology , mRNA, bioprocess, cell therapy, gene therapy, lab filtration, and molecular biology